USSTOCK.TODAY
Pre-Market
Log in Sign up

Pfizer signs $2.6 billion licensing agreement with Starna for autoimmune disease treatment

Nasdaq +1 · ·by G4L

PFE Pfizer Inc
$28.06 -1.44%
View chart & analysis →
  1. 1Pfizer signed a licensing agreement with Starna Therapeutics that includes a $330 million upfront payment from Pfizer.
  2. 2Starna's development and commercialization milestones total up to $2.3 billion.
  3. 3CEO Albert Bourla said the competitive landscape will shift from traditional Western big pharma to a structure between Western companies and China following China's significant growth in recent years.

So what's the key point?

Pfizer has signed an agreement to develop autoimmune disease treatments with Starna. This deal, worth up to $2.3 billion, will support the development of new treatments.

Source Nasdaq +1 · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →